-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, it has been reported that Beijing Tongrentang issued a price adjustment notice, raising the selling price of Angong Niuhuang Pills (3g*pills/box) from 780 yuan to 860 yuan, an increase of about 10%.
The price will be from December 1st.
Start execution
.
It is worth noting that this is not the first price increase of Tongrentang Angong Niuhuang Wan.
In 2012, Tongrentang increased its price from 350 yuan to 560 yuan, an increase of nearly 60%; in December 2019, Tongrentang increased its price from 560 yuan.
The yuan rose to 780 yuan, an increase of about 40%, and this price will be implemented from January 2020
.
According to data, Tongrentang's revenue is mainly concentrated in the five major sectors of cardiovascular and cerebrovascular products, tonic products, heat-clearing products, gynecology products and other products
.
Among them, Angong Niuhuang Pill is a cardio-cerebrovascular product.
This sector contributed 3.
004 billion yuan in revenue to Tongrentang in 2020, ranking among the top five sectors
.
Regarding the price increase, Tongrentang said: “The price adjustment is mainly based on the increase in the raw material prices of Angong Niuhuang Wan
.
” It is reported that the main raw materials of the medicine include bezoar, musk, buffalo horn concentrate powder, pearls, coptis, gardenia, turmeric, cinnabar, realgar, borneol and so on
.
Analysis believes that the price increase of Angong Niuhuang Pills is actually not without a trace
.
Since the beginning of this year, many of the main materials of Angong Niuhuang Wan have seen price increases
.
Take turmeric as an example, the market trend is very active, the popularity is quite high, and the price increase rate has exceeded 30%
.
At that time, some people in the industry predicted that the price increase of Chinese medicinal materials would cause the cost of pharmaceutical companies to rise, and some pharmaceutical companies would have to raise the prices of end products.
In the future, some Chinese patent medicines might usher in price increases
.
In fact, this year, in addition to Angong Niuhuang Wan, Pien Tzehuang, which also uses bezoar and musk as raw materials, indeed ushered in a price increase in June this year after the price increase of raw materials last year
.
Specifically, in January 2020, Pien Tze Huang issued an announcement stating that in view of the increase in the main raw materials and labor costs of Pien Tze Huang products, Pien Tze Huang decided to increase the price of the leading product, Pien Tze Huang, from the date of the announcement
.
Among them, the retail price in the domestic market has been increased from 530 yuan/tablet to 590 yuan/tablet
.
In June this year, the original price of 590 yuan/tablet (3g) of Pien Tze Huang was fired up to thousands of yuan, and even close to 2,000 yuan/tablet at high level
.
In addition to the price increase of Tongrentang Angong Niuhuang Pills, some other large varieties have also seen price increases in recent times
.
For example, in October this year, "Sining", a commonly used drug for Parkinson's syndrome, was out of stock on the market.
Many patients and their families reported that they could not get this drug in the hospital, and could only be 10 times or even higher than the medical insurance price.
Buy at 20 times the price
.
On the whole, although the reasons for the price increase of many drugs are different, most of them are inseparable from the price increase of the bulk drug itself and the adjustment of the drug production line
.
In this regard, the industry believes that, for related companies, it is necessary to strengthen the connection and technical guidance with Chinese herbal medicine growers from the aspect of planting, to ensure the orderly development of the supply side of the medicinal materials, and to continuously improve the quality of Chinese medicinal materials to ensure qualified Chinese medicines.
The normal supply of materials
.
As for consumers, they should purchase rationally and avoid hoarding and abuse; at the same time, pharmacists also need to fulfill their obligation to remind the expiration date of drugs
.
The price will be from December 1st.
Start execution
.
It is worth noting that this is not the first price increase of Tongrentang Angong Niuhuang Wan.
In 2012, Tongrentang increased its price from 350 yuan to 560 yuan, an increase of nearly 60%; in December 2019, Tongrentang increased its price from 560 yuan.
The yuan rose to 780 yuan, an increase of about 40%, and this price will be implemented from January 2020
.
According to data, Tongrentang's revenue is mainly concentrated in the five major sectors of cardiovascular and cerebrovascular products, tonic products, heat-clearing products, gynecology products and other products
.
Among them, Angong Niuhuang Pill is a cardio-cerebrovascular product.
This sector contributed 3.
004 billion yuan in revenue to Tongrentang in 2020, ranking among the top five sectors
.
Regarding the price increase, Tongrentang said: “The price adjustment is mainly based on the increase in the raw material prices of Angong Niuhuang Wan
.
” It is reported that the main raw materials of the medicine include bezoar, musk, buffalo horn concentrate powder, pearls, coptis, gardenia, turmeric, cinnabar, realgar, borneol and so on
.
Analysis believes that the price increase of Angong Niuhuang Pills is actually not without a trace
.
Since the beginning of this year, many of the main materials of Angong Niuhuang Wan have seen price increases
.
Take turmeric as an example, the market trend is very active, the popularity is quite high, and the price increase rate has exceeded 30%
.
At that time, some people in the industry predicted that the price increase of Chinese medicinal materials would cause the cost of pharmaceutical companies to rise, and some pharmaceutical companies would have to raise the prices of end products.
In the future, some Chinese patent medicines might usher in price increases
.
In fact, this year, in addition to Angong Niuhuang Wan, Pien Tzehuang, which also uses bezoar and musk as raw materials, indeed ushered in a price increase in June this year after the price increase of raw materials last year
.
Specifically, in January 2020, Pien Tze Huang issued an announcement stating that in view of the increase in the main raw materials and labor costs of Pien Tze Huang products, Pien Tze Huang decided to increase the price of the leading product, Pien Tze Huang, from the date of the announcement
.
Among them, the retail price in the domestic market has been increased from 530 yuan/tablet to 590 yuan/tablet
.
In June this year, the original price of 590 yuan/tablet (3g) of Pien Tze Huang was fired up to thousands of yuan, and even close to 2,000 yuan/tablet at high level
.
In addition to the price increase of Tongrentang Angong Niuhuang Pills, some other large varieties have also seen price increases in recent times
.
For example, in October this year, "Sining", a commonly used drug for Parkinson's syndrome, was out of stock on the market.
Many patients and their families reported that they could not get this drug in the hospital, and could only be 10 times or even higher than the medical insurance price.
Buy at 20 times the price
.
On the whole, although the reasons for the price increase of many drugs are different, most of them are inseparable from the price increase of the bulk drug itself and the adjustment of the drug production line
.
In this regard, the industry believes that, for related companies, it is necessary to strengthen the connection and technical guidance with Chinese herbal medicine growers from the aspect of planting, to ensure the orderly development of the supply side of the medicinal materials, and to continuously improve the quality of Chinese medicinal materials to ensure qualified Chinese medicines.
The normal supply of materials
.
As for consumers, they should purchase rationally and avoid hoarding and abuse; at the same time, pharmacists also need to fulfill their obligation to remind the expiration date of drugs
.
